BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 26896825)

  • 1. Postmolar choriocarcinoma: An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia.
    Strohl AE; Lurain JR
    Gynecol Oncol; 2016 May; 141(2):276-280. PubMed ID: 26896825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
    Lurain JR; Chapman-Davis E; Hoekstra AV; Schink JC
    J Reprod Med; 2012; 57(7-8):283-7. PubMed ID: 22838241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy.
    Chapman-Davis E; Hoekstra AV; Rademaker AW; Schink JC; Lurain JR
    Gynecol Oncol; 2012 Jun; 125(3):572-5. PubMed ID: 22449733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.
    Maestá I; Nitecki R; Horowitz NS; Goldstein DP; de Freitas Segalla Moreira M; Elias KM; Berkowitz RS
    Gynecol Oncol; 2018 Jan; 148(1):161-167. PubMed ID: 29092742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study.
    Braga A; Paiva G; Ghorani E; Freitas F; Velarde LGC; Kaur B; Unsworth N; Lozano-Kuehne J; Dos Santos Esteves APV; Rezende Filho J; Amim J; Aguiar X; Sarwar N; Elias KM; Horowitz NS; Berkowitz RS; Seckl MJ
    Lancet Oncol; 2021 Aug; 22(8):1188-1198. PubMed ID: 34181884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia.
    Maestá I; Growdon WB; Goldstein DP; Bernstein MR; Horowitz NS; Rudge MV; Berkowitz RS
    Gynecol Oncol; 2013 Aug; 130(2):312-6. PubMed ID: 23707672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom.
    Taylor F; Short D; Winter MC; Tidy J; Savage PM; Sarwar N; Hancock BW; Seckl MJ; Coleman RE
    Gynecol Oncol; 2015 Feb; 136(2):258-63. PubMed ID: 25542400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma?
    Braga A; Campos V; Filho JR; Lin LH; Sun SY; de Souza CB; da Silva RCAF; Leal EAS; Silveira E; Maestá I; Madi JM; Uberti EH; Viggiano M; Elias KM; Horowitz N; Berkowitz RS
    Gynecol Oncol; 2018 Feb; 148(2):239-246. PubMed ID: 29248195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia.
    Li L; Wan X; Feng F; Ren T; Yang J; Zhao J; Jiang F; Xiang Y
    BMC Cancer; 2018 May; 18(1):585. PubMed ID: 29792175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
    Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
    Al-Husaini H; Soudy H; Darwish A; Ahmed M; Eltigani A; Edesa W; Elhassan T; Omar A; Elghamry W; Al-Hashem H; Al-Hayli S; Madkhali I; Ahmad S; Al-Badawi IA
    Clin Transl Oncol; 2015 May; 17(5):409-15. PubMed ID: 25398721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of extremely high risk and resistant gestational trophoblastic neoplasia patients in King Chulalongkorn Memorial Hospital.
    Oranratanaphan S; Lertkhachonsuk R
    Asian Pac J Cancer Prev; 2014; 15(2):925-8. PubMed ID: 24568520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics of Gestational Trophoblastic Neoplasia: A 15-Year Hospital-Based Study.
    Sun R; Zhang Y; Zheng W; Tian Q; An R; Xue Y
    Int J Gynecol Cancer; 2016 Jan; 26(1):216-21. PubMed ID: 26512786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia.
    Maestá I; Nitecki R; Desmarais CCF; Horowitz NS; Goldstein DP; Elias KM; Berkowitz RS
    Gynecol Oncol; 2020 May; 157(2):372-378. PubMed ID: 32037196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between race and clinical characteristics, extent of disease, and response to chemotherapy in patients with low-risk gestational trophoblastic neoplasia.
    Maestá I; Berkowitz RS; Goldstein DP; Bernstein MR; Ramírez LA; Horowitz NS
    Gynecol Oncol; 2015 Jul; 138(1):50-4. PubMed ID: 25933681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia.
    Winter MC; Tidy JA; Hills A; Ireson J; Gillett S; Singh K; Hancock BW; Coleman RE
    Gynecol Oncol; 2016 Dec; 143(3):565-570. PubMed ID: 27756557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.
    Gulia S; Bajpai J; Gupta S; Maheshwari A; Deodhar K; Kerkar RA; Seth V; Rekhi B; Menon S
    Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):39-44. PubMed ID: 24051171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.